The Group's principal activity is in-licensing, developing and out-licensing technologies, principally in the drug development area, generating revenues from royalties and licensing milestone payments and growing value in its development pipeline. The acquires rights to early-stage pharmaceuticals and other medical technologies from a global network of corporations, universities and research institutions. The drug development programme are in the field of oncology, ageing, neuroscience and drug repositioning. The Group's products are Varisolve, Misopess, Benefix, Campath, Infecton, Juvidex and Symadex.

URL : http://www.btgplc.com